Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 5,514Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 15BRISTOL MYERS SQUIBB

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

APIXABAN

US Patent Number : 6967208

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202155

Patent Use Code : U-1501

Delist Requested :

Patent Use Description : PROPHYLAXIS OF DEEP VE...

Patent Expiration Date : 2026-11-21

blank

02

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

APIXABAN

US Patent Number : 6967208

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202155

Patent Use Code : U-1200

Delist Requested :

Patent Use Description : REDUCING THE RISK OF S...

Patent Expiration Date : 2026-11-21

blank

03

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

APIXABAN

US Patent Number : 6967208

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202155

Patent Use Code : U-1302

Delist Requested :

Patent Use Description : TREATMENT OF PULMONARY...

Patent Expiration Date : 2026-11-21

blank

04

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

APIXABAN

US Patent Number : 6967208

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202155

Patent Use Code : U-1729

Delist Requested :

Patent Use Description : REDUCE THE RISK OF REC...

Patent Expiration Date : 2026-11-21

blank

05

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

APIXABAN

US Patent Number : 6967208

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202155

Patent Use Code : U-1301

Delist Requested :

Patent Use Description : TREATMENT OF DEEP VEIN...

Patent Expiration Date : 2026-11-21

blank

06

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

APIXABAN

US Patent Number : 6967208

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202155

Patent Use Code : U-1200

Delist Requested :

Patent Use Description : REDUCING THE RISK OF S...

Patent Expiration Date : 2026-11-21

blank

07

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

APIXABAN

US Patent Number : 6967208

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202155

Patent Use Code : U-1730

Delist Requested :

Patent Use Description : REDUCE THE RISK OF REC...

Patent Expiration Date : 2026-11-21

blank

08

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

APIXABAN

US Patent Number : 6967208

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202155

Patent Use Code : U-1301

Delist Requested :

Patent Use Description : TREATMENT OF DEEP VEIN...

Patent Expiration Date : 2026-11-21

blank

09

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

APIXABAN

US Patent Number : 6967208

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202155

Patent Use Code : U-1167

Delist Requested :

Patent Use Description : PROPHYLAXIS OF DEEP VE...

Patent Expiration Date : 2026-11-21

blank

10

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

APIXABAN

US Patent Number : 6967208

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202155

Patent Use Code : U-1302

Delist Requested :

Patent Use Description : TREATMENT OF PULMONARY...

Patent Expiration Date : 2026-11-21

blank